On April 27, 2026, the FDA issued multiple recalls affecting food importers in the Middle East, Southeast Asia, and Africa. Key risks include cyclamate (a banned sweetener) in Chinese preserved vegetables and olive skewers, undeclared allergens in seasonings and snacks, and Class I recalls for dietary supplements containing undeclared sildenafil/tadalafil. Importers must immediately verify ingredient labels and supplier documentation.
1. [Risk 5/5] Cyclamate in Chinese Preserved Fruits & Vegetables — FDA Recall H-0657-2026 & H-0658-2026
The FDA completed recalls for MEI YU CHENG DA TRADING INC's DADI NONGFU DRIED SALT CHILLI VEGETABLE and Olive Skewers due to sodium cyclamate, a sweetener banned in the U.S. This Class III recall signals FDA targeting of Chinese-style preserved products.
Action Required (today):
- Audit all preserved fruits, olives, salted vegetables, and candied snacks for 'sodium cyclamate', 'cyclamate', or '甜蜜素' in ingredient lists.
- Request third-party lab reports from suppliers confirming no cyclamate content.
- For in-transit U.S. orders, notify customers to halt sales and arrange return or destruction.
- Replace cyclamate with FDA-allowed sweeteners (sucrose, aspartame, sucralose, stevia).
Source: FDA recall #H-0657-2026 & #H-0658-2026
2. [Risk 5/5] Undeclared Allergens in Seasonings & Snacks — Multiple FDA Recalls
Five FDA recalls today involve undeclared allergens: Zarlengo ice cream (soy lecithin not declared), Riverence smoked trout dip (milk), F&S Fresh Foods sandwiches (sesame), and Blueroot Health vitamins (egg/soy/hazelnut). These Class II recalls can lead to product detention and customer claims.
Action Required (today):
- Cross-check ingredient lists against 'Contains' statements for all U.S.-bound compound seasonings, sauces, and snacks.
- Ensure ingredients like whey protein, casein, milk powder, soy protein isolate, sesame paste, sesame oil, peanut butter, and almond flour are explicitly declared in 'Contains'.
- Add 'May contain [allergen]' warnings on packaging for products with cross-contact risk.
- Confirm allergen labeling requirements with customers in target markets (U.S., EU, ASEAN).
Source: FDA recalls #H-0652-2026, #H-0662-2026, #H-0659-2026, #H-0663-2026
3. [Risk 4/5] Class I Recalls for Drug-Adulterated 'Male Enhancement' Supplements
The FDA issued three Class I recalls for Blue Bull/Red Bull/Boner Bears supplements containing undeclared sildenafil and tadalafil. While your core products are snacks and seasonings, any 'functional' items (e.g., ginseng-infused snacks, herbal seasonings) face heightened scrutiny.
Action Required (today):
- Identify any U.S.-bound 'functional' or 'health' products (e.g., with ginseng, maca, goji berry).
- Ensure all functional ingredients have FDA GRAS status or an NDI notification.
- Prohibit any pharmaceutical ingredients (sildenafil, tadalafil, sibutramine) in food products.
- Conduct third-party testing for banned drug residues before shipment.
Source: FDA recalls #H-0654-2026, #H-0655-2026, #H-0653-2026